Disorders of serum omega-3 fatty acid composition in dialyzed patients,and their associations with fat mass |
| |
Authors: | Małgorzata Sikorska-Wiśniewska Adriana Mika Tomasz Śledziński Sylwia Małgorzewicz Piotr Stepnowski Bolesław Rutkowski |
| |
Affiliation: | 1. Department of Nephrology, Transplantology and Internal Medicine, Medical University of Gdańsk, Gdańsk, Poland;2. Department of Environmental Analysis, Faculty of Chemistry, University of Gdańsk, Gdańsk, Poland;3. Department of Pharmaceutical Biochemistry, Medical University of Gdańsk, Gdańsk, Poland;4. Department of Clinical Nutrition, Medical University of Gdańsk, Gdańsk, Poland |
| |
Abstract: | Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular mortality. Lipid disorders, a constant feature of CKD, might contribute to this state. The aim of this study was to evaluate n-3 polyunsaturated fatty acids (PUFA) composition in CKD patients treated with dialysis, in comparison to the general population and to assess possible associations between the n-3 PUFA profile and anthropometric variables. Thirty-three prevalent dialysis patients were studied and compared with an age- and sex-adjusted control group of 22 patients. Fatty acid composition in serum was analyzed by gas chromatography with a mass spectrometer detector (GC-MS) and anthropometric measures were assessed by bioimpedance spectroscopy. The fatty acid profile of dialyzed patients was characterized by a significantly lower percentage content of n-3 PUFA. For α-linolenic acid (ALA), it was 0.21?±?0.09% in dialysis patients versus 0.33?±?0.11% in the control group (p?.001). For eicosapentanoic acid (EPA), 0.59?±?0.23% versus 1.15?±?0.87% (p?.001), and for docosahexaenoic acid (DHA) 1.11?±?0.50% versus 1.75?±?0.87% (p?.001), respectively. The amount of n-3 PUFA decreased with time on dialysis and it correlated positively with body fat mass. For DHA, this correlation was r?=?.48 (p?.01) and for EPA r?=?.40 (p?.05). Patients with CKD have a relatively low content of n-3 PUFA which may contribute to their high cardiovascular risk. Patients with a higher content of body fat are characterized by a favorable fatty acid composition. |
| |
Keywords: | Omega-3 long-chain polyunsaturated fatty acids hemodialysis peritoneal dialysis chronic kidney disease lipid disorders |
|
|